Back to Search Start Over

Positive data presented from ongoing phase II immunotherapy study for melanoma

Source :
Science Letter. October 11, 2005, 1054
Publication Year :
2005

Abstract

Oxxon Therapeutics, Inc., reported positive interim data from its ongoing phase II immunotherapy study in patients with advanced melanoma. The data were presented at an oral session at the 6th [...]

Details

Language :
English
ISSN :
15389111
Database :
Gale General OneFile
Journal :
Science Letter
Publication Type :
News
Accession number :
edsgcl.267934140